$ALT
Altimmune Inc Stock $alt

$alt Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000155837021015292 Filed on November 09, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2020 Q4
Revenue	$3.278M	$157.6K	$2.310M
YoY Change	41.89%	-94.64%	298.28%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$3.777M	$4.156M	$4.110M
YoY Change	-8.1%	-1.52%	104.48%
% of Gross Profit
Research & Development	$20.19M	$29.21M	$8.950M
YoY Change	125.53%	71.38%	211.85%
% of Gross Profit
Depreciation & Amortization	$117.3K	$100.0K	$120.0K
YoY Change	-2.26%	0.0%	71.43%
% of Gross Profit
Operating Expenses	$23.96M	$33.36M	$13.06M
YoY Change	83.48%	56.91%	167.08%
Operating Profit		-$33.20M
YoY Change		81.2%
Interest Expense	$176.0K	$32.87K	$40.00K
YoY Change	340.0%	1344.66%	-78.95%
% of Operating Profit
Other Income/Expense, Net	-$80.64K	-$306.6K	-$20.00K
YoY Change	303.2%	-525.39%	-200.0%
Pretax Income	-$23.89M	-$33.51M	-$10.73M
YoY Change	122.64%	83.6%	161.71%
Income Tax	$0.00	$0.00	-$110.0K
% Of Pretax Income
Net Earnings	-$23.89M	-$33.51M	-$10.62M
YoY Change	124.95%	88.58%	159.02%
Net Earnings / Revenue	-728.85%	-21268.66%	-459.74%
Basic Earnings Per Share		-$0.81
Diluted Earnings Per Share	-$560.8K	-$0.81	-$292.0K
COMMON SHARES
Basic Shares Outstanding	39.74M	39.71M	33.07M
Diluted Shares Outstanding		41.37M

Balance Sheet

Concept	2021 Q4	2021 Q3	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$190.3M	$199.9M	$215.9M
YoY Change	-11.86%	-3.34%	480.38%
Cash & Equivalents	$190.3M	$174.9M	$115.9M
Short-Term Investments	$0.00	$25.02M	$100.0M
Other Short-Term Assets	$7.987M	$7.329M	$1.900M
YoY Change	320.36%	463.73%	280.0%
Inventory
Prepaid Expenses
Receivables	$428.8K	$1.574M	$4.600M
Other Receivables	$5.410M	$9.476M	$7.800M
Total Short-Term Assets	$204.1M	$218.3M	$230.3M
YoY Change	-11.35%	0.06%	484.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.448M	$4.718M	$1.057M
YoY Change	37.0%	352.83%	-4.28%
Goodwill
YoY Change
Intangibles	$12.42M	$12.99M	$12.82M
YoY Change	-3.16%	1.55%	0.72%
Long-Term Investments
YoY Change
Other Assets	$872.0K	$931.9K	$977.2K
YoY Change	-10.77%	968.76%	660.22%
Total Long-Term Assets	$14.74M	$18.64M	$14.86M
YoY Change	-0.8%	25.43%	1.33%
TOTAL ASSETS
Total Short-Term Assets	$204.1M	$218.3M	$230.3M
Total Long-Term Assets	$14.74M	$18.64M	$14.86M
Total Assets	$218.9M	$236.9M	$245.1M
YoY Change	-10.71%	1.68%	353.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.034M	$6.083K	$612.3K
YoY Change	232.19%	-99.3%	3258.34%
Accrued Expenses	$10.15M	$19.12M	$11.41M
YoY Change	-11.02%	252.86%	192.16%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$18.28M	$19.13M	$12.02M
YoY Change	52.04%	203.91%	206.41%
LONG-TERM LIABILITIES
Long-Term Debt	$1.454M	$1.566M	$1.828M
YoY Change	-20.48%	-18.7%	-1.95%
Other Long-Term Liabilities	$80.00K	$85.49K	$110.3K
YoY Change	-27.48%	-25.84%	-15.27%
Total Long-Term Liabilities	$1.534M	$1.651M	$1.939M
YoY Change	-20.88%	-19.1%	-2.82%
TOTAL LIABILITIES
Total Short-Term Liabilities	$18.28M	$19.13M	$12.02M
Total Long-Term Liabilities	$1.534M	$1.651M	$1.939M
Total Liabilities	$19.73M	$27.64M	$19.24M
YoY Change	2.55%	-16.96%	125.34%
SHAREHOLDERS EQUITY
Retained Earnings	-$293.2M	-$269.3M	-$186.4M
YoY Change	57.26%	53.18%	35.7%
Common Stock	$4.000K	$3.959K	$3.697K
YoY Change	8.2%	20.37%	145.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$199.1M	$209.3M	$225.9M
YoY Change
Total Liabilities & Shareholders Equity	$218.9M	$236.9M	$245.1M
YoY Change	-10.71%	1.68%	353.43%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2020 Q4
OPERATING ACTIVITIES
Net Income	-$23.89M	-$33.51M	-$10.62M
YoY Change	124.95%	88.58%	159.02%
Depreciation, Depletion And Amortization	$117.3K	$100.0K	$120.0K
YoY Change	-2.26%	0.0%	71.43%
Cash From Operating Activities	-$21.97M	-$17.78M	-$13.42M
YoY Change	63.69%	87.11%	571.0%
INVESTING ACTIVITIES
Capital Expenditures	-$151.8K	-$114.1K	-$140.0K
YoY Change	8.44%	42.61%
Acquisitions
YoY Change
Other Investing Activities	$25.02M	$18.53M	-$36.72M
YoY Change	-168.14%	-138.75%	73340.0%
Cash From Investing Activities	$24.87M	$18.41M	-$36.86M
YoY Change	-167.47%	-138.45%	61333.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	12.54M	124.4K	22.71M
YoY Change	-44.8%	-99.91%	56675.0%
NET CHANGE
Cash From Operating Activities	-21.97M	-17.78M	-13.42M
Cash From Investing Activities	24.87M	18.41M	-36.86M
Cash From Financing Activities	12.54M	124.4K	22.71M
Net Change In Cash	15.44M	761.2K	-27.57M
YoY Change	-155.99%	-99.03%	1264.85%
FREE CASH FLOW
Cash From Operating Activities	-$21.97M	-$17.78M	-$13.42M
Capital Expenditures	-$151.8K	-$114.1K	-$140.0K
Free Cash Flow	-$21.82M	-$17.66M	-$13.28M
YoY Change	64.27%	87.49%	564.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20878
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
	dei	Entity Central Index Key EntityCentralIndexKey	0001326190
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Out Of Level3 FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3	0
CY2020	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Out Of Level3 FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3	0
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39702768
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37142946
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.81
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.54
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.79
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.74
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P12Y2M18D
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-32587
	dei	Entity Registrant Name EntityRegistrantName	ALTIMMUNE, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-2726770
	dei	Entity Address Address Line1 EntityAddressAddressLine1	910 Clopper Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 201S
	dei	Entity Address City Or Town EntityAddressCityOrTown	Gaithersburg
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
	dei	City Area Code CityAreaCode	240
	dei	Local Phone Number LocalPhoneNumber	654-1450
	dei	Security12b Title Security12bTitle	Common stock, par value $0.0001 per share
	dei	Trading Symbol TradingSymbol	ALT
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	39738625
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	174863565
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	115917807
CY2021Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	34174
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	34174
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	174897739
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	115951981
CY2021Q3	us-gaap	Short Term Investments ShortTermInvestments	25020738
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	100005558
CY2021Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1573760
CY2020Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	4610202
CY2021Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	9476435
CY2020Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	7762793
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7294360
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1926675
CY2021Q3	us-gaap	Assets Current AssetsCurrent	218263032
CY2020Q4	us-gaap	Assets Current AssetsCurrent	230257209
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4718146
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1056920
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12993575
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12823846
CY2021Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	931904
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	977238
CY2021Q3	us-gaap	Assets Assets	236906657
CY2020Q4	us-gaap	Assets Assets	245115213
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	6083
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	612293
CY2021Q3	alt	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	19120902
CY2020Q4	alt	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	11408154
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	19126985
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12020447
CY2021Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	6950000
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	5390000
CY2021Q3	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	1565611
CY2020Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	1828443
CY2021Q3	us-gaap	Liabilities Liabilities	27642596
CY2020Q4	us-gaap	Liabilities Liabilities	19238890
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39702768
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37142946
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	3959
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	3697
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	483582367
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	417337742
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-269282102
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-186420599
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5040163
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5044517
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	209264061
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	225876323
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	236906657
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	245115213
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	157559
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2937991
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1132698
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5872321
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	29205739
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17041975
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	54356051
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	40823756
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4155928
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-272149
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4220238
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11636001
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9097511
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	8070000
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	33361667
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	21262213
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	319568
	us-gaap	Operating Expenses OperatingExpenses	74062052
	us-gaap	Operating Expenses OperatingExpenses	49921267
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-33204108
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-18324222
	us-gaap	Operating Income Loss OperatingIncomeLoss	-72929354
	us-gaap	Operating Income Loss OperatingIncomeLoss	-44048946
CY2021Q3	us-gaap	Interest Expense InterestExpense	32866
CY2020Q3	us-gaap	Interest Expense InterestExpense	2275
	us-gaap	Interest Expense InterestExpense	66763
	us-gaap	Interest Expense InterestExpense	7468
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	12485
CY2020Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	45127
	us-gaap	Investment Income Interest InvestmentIncomeInterest	87847
	us-gaap	Investment Income Interest InvestmentIncomeInterest	278154
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-286199
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	29218
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-293233
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	48882
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-306580
CY2020Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	72070
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-33510688
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18252152
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-73201503
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-43729378
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-482017
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5306678
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-33510688
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-17770135
	us-gaap	Net Income Loss NetIncomeLoss	-73201503
	us-gaap	Net Income Loss NetIncomeLoss	-38422700
CY2021Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1923
CY2020Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-10569
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	4354
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-22116
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-33512611
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-17780704
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-73197149
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-38444816
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.81
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.54
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.79
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.74
CY2021Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	41370768
CY2020Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	33056971
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	40843905
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	22058424
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	225876323
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1218351
CY2021Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-92506
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	106001
CY2021Q1	alt	Retirement Of Common Sock In Exchange For Common Stock Warrant RetirementOfCommonSockInExchangeForCommonStockWarrant	-17200000
CY2021Q1	alt	Issuance Of Common Stock Warrant In Exchange For Retirement Of Common Stock IssuanceOfCommonStockWarrantInExchangeForRetirementOfCommonStock	-17200000
CY2021Q1	alt	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	10000
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	5136
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-14864108
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	246437428
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1484829
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	94429
CY2021Q2	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-91121
CY2021Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1141
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-24826707
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	241277972
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1496884
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5970
CY2021Q3	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-122625
CY2021Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	118471
CY2021Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1923
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-33510688
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	209264061
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	45520146
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	214921
CY2020Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-17079
CY2020Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	56739
CY2020Q1	alt	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	39974
CY2020Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-32435
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-3885649
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	41896617
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	330510
CY2020Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	36175
CY2020Q2	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-46389
CY2020Q2	alt	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	31270163
CY2020Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	20888
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-16766916
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	79521777
CY2020Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	90270
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1320089
CY2020Q3	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-114572
CY2020Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	78732
CY2020Q3	alt	Stock Issued During Period Value Common Stock And Pre Funded Warrants In Public Offering Net StockIssuedDuringPeriodValueCommonStockAndPreFundedWarrantsInPublicOfferingNet	124027815
CY2020Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2834107
CY2020Q3	alt	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	9728321
CY2020Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-10569
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-17770135
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	199705835
	us-gaap	Profit Loss ProfitLoss	-73201503
	us-gaap	Profit Loss ProfitLoss	-38422700
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1560000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	22320000
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	8070000
	us-gaap	Share Based Compensation ShareBasedCompensation	4200064
	us-gaap	Share Based Compensation ShareBasedCompensation	1865520
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	434009
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	218932
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-297135
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	44323
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3036442
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2815343
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5263432
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	636943
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-606210
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	856653
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	6916132
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1199708
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	1713642
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	5564759
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-56271005
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21023255
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	82406000
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	39385689
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	7591962
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	74413135
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11970179
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	100329
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	189649
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	98893
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	62654210
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35226668
	alt	Payments Of Deferred Offering Costs PaymentsOfDeferredOfferingCosts	118522
	alt	Payments Of Deferred Offering Costs PaymentsOfDeferredOfferingCosts	160522
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	41038458
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	52356204
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25614836
	alt	Proceeds From Issuance Of Common Stock And Pre Funded Warrants In Public Offering Net ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsInPublicOfferingNet	124027815
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	632000
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	632000
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	224472
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	135471
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	100399
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	126445
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	52562553
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	190782503
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	58945758
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	134532580
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	115951981
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8996860
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	174897739
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	143529440
	us-gaap	Interest Paid Net InterestPaidNet	1791
	alt	Addition Operating Lease Liability And Right Of Use Asset AdditionOperatingLeaseLiabilityAndRightOfUseAsset	72047
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The preparation of these financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The extent to which the COVID-19 pandemic, including any resurgences or the emergence of new variants, may directly or indirectly impact the Company’s business, financial condition, and results of operations is highly uncertain and subject to change. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company considered the potential impact of the COVID-19 pandemic on the Company’s estimates and assumptions and determined that there was not a material impact to the Company’s unaudited consolidated financial statements as of and for the three and nine months ended September 30, 2021. However, actual results could differ from those estimates and there may be changes to the Company’s estimates in future periods.</p>
CY2021Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	25020738
CY2021Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	25020738
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	100009912
CY2020Q4	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	-4354
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	100005558
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Into Level3 FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3	0
CY2020	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Into Level3 FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3	0
CY2020Q4	alt	Assets Or Liabilities Measured At Fair Value On Non Recurring Basis AssetsOrLiabilitiesMeasuredAtFairValueOnNonRecurringBasis	0
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	8100000
CY2021Q3	us-gaap	Property Plant And Equipment Fair Value Disclosure PropertyPlantAndEquipmentFairValueDisclosure	3300000
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6647274
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2655731
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1929128
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1598811
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4718146
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1056920
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	8100000
CY2021Q3	us-gaap	Depreciation Depreciation	100000
CY2020Q3	us-gaap	Depreciation Depreciation	100000
	us-gaap	Depreciation Depreciation	200000
	us-gaap	Depreciation Depreciation	200000
CY2021Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1359436
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	784828
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	574608
CY2021Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	13778403
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	784828
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12993575
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1169787
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	764908
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	404879
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	13588754
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	764908
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12823846
	alt	Non Cancellable Lease Maturity Period NonCancellableLeaseMaturityPeriod	2026-06
CY2021Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	100000
	us-gaap	Operating Lease Expense OperatingLeaseExpense	400000
CY2020Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	100000
	us-gaap	Operating Lease Expense OperatingLeaseExpense	300000
CY2021Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	100000
	us-gaap	Operating Lease Payments OperatingLeasePayments	400000
CY2020Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	100000
	us-gaap	Operating Lease Payments OperatingLeasePayments	300000
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1631867
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1824840
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	844222
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	903825
CY2021Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y7M6D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y3M18D
CY2021Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.072
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.073
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	356716
CY2021Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	19753
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1350194
CY2021Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2006675
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2351599
CY2021Q3	us-gaap	Interest Payable Current InterestPayableCurrent	19423
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	13016
CY2021Q3	alt	Accrued Research And Development AccruedResearchAndDevelopment	15943874
CY2020Q4	alt	Accrued Research And Development AccruedResearchAndDevelopment	7316876
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	401743
CY2021Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	729434
CY2020Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	19753
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19120902
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11408154
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	5390000
CY2019Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	2750000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1560000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	22320000
CY2021Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	6950000
CY2020Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	25070000
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	85487
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	110319
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1828443
	alt	Number Of Warrants Exercised For Conversion Of Securities NumberOfWarrantsExercisedForConversionOfSecurities	1420
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1565611
CY2021Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2776191
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1777611
	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1000000
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1230124
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1468124
CY2021Q3	alt	Economic Conditional Incentive Grants EconomicConditionalIncentiveGrants	250000
CY2020Q4	alt	Economic Conditional Incentive Grants EconomicConditionalIncentiveGrants	250000
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2612585
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.74
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y10M24D
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	14034500
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	984613
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.45
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y9M18D
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	7851439
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1627972
	alt	Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedOutstandingWeightedAverageExercisePrice	10.73
	alt	Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedOutstandingWeightedAverageRemainingContractualTerm	P6Y
CY2021Q3	alt	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOutstandingIntrinsicValue	6183061
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1496884
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1320089
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4200064
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1865520
CY2020Q3	us-gaap	Income Tax Examination Liability Refund Adjustment From Settlement With Taxing Authority IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority	5300000

Files In Submission

Name	View Source	Status
0001558370-21-015292-index-headers.html	Edgar Link	pending
0001558370-21-015292-index.html	Edgar Link	pending
0001558370-21-015292.txt	Edgar Link	pending
0001558370-21-015292-xbrl.zip	Edgar Link	pending
alt-20210930.xsd	Edgar Link	pending
alt-20210930x10q.htm	Edgar Link	pending
alt-20210930x10q002.jpg	Edgar Link	pending
alt-20210930x10q_htm.xml	Edgar Link	completed
alt-20210930xex10d1.htm	Edgar Link	pending
alt-20210930xex10d1001.jpg	Edgar Link	pending
alt-20210930xex10d1002.jpg	Edgar Link	pending
alt-20210930xex10d1003.jpg	Edgar Link	pending
alt-20210930xex10d1004.jpg	Edgar Link	pending
alt-20210930xex10d1005.jpg	Edgar Link	pending
alt-20210930xex10d1006.jpg	Edgar Link	pending
alt-20210930xex10d1007.jpg	Edgar Link	pending
alt-20210930xex10d1008.jpg	Edgar Link	pending
alt-20210930xex10d1009.jpg	Edgar Link	pending
alt-20210930xex10d1010.jpg	Edgar Link	pending
alt-20210930xex10d1011.jpg	Edgar Link	pending
alt-20210930xex10d1013.jpg	Edgar Link	pending
alt-20210930xex10d1014.jpg	Edgar Link	pending
alt-20210930xex10d1015.jpg	Edgar Link	pending
alt-20210930xex10d1016.jpg	Edgar Link	pending
alt-20210930xex10d1018.jpg	Edgar Link	pending
alt-20210930xex10d1043.jpg	Edgar Link	pending
alt-20210930xex10d1044.jpg	Edgar Link	pending
alt-20210930xex10d1047.jpg	Edgar Link	pending
alt-20210930xex10d1048.jpg	Edgar Link	pending
alt-20210930xex10d1050.jpg	Edgar Link	pending
alt-20210930xex10d1053.jpg	Edgar Link	pending
alt-20210930xex10d1055.jpg	Edgar Link	pending
alt-20210930xex10d1056.jpg	Edgar Link	pending
alt-20210930xex10d1057.jpg	Edgar Link	pending
alt-20210930xex10d1058.jpg	Edgar Link	pending
alt-20210930xex31d1.htm	Edgar Link	pending
alt-20210930xex31d2.htm	Edgar Link	pending
alt-20210930xex32d1.htm	Edgar Link	pending
alt-20210930xex32d2.htm	Edgar Link	pending
alt-20210930_cal.xml	Edgar Link	unprocessable
alt-20210930_def.xml	Edgar Link	unprocessable
alt-20210930_lab.xml	Edgar Link	unprocessable
alt-20210930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALT
Altimmune Inc Stock $alt

2021 Q4 Form 10-Q Financial Statement

#000155837021015292 Filed on November 09, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALT Altimmune Inc Stock $alt

2021 Q4 Form 10-Q Financial Statement

#000155837021015292 Filed on November 09, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALT
Altimmune Inc Stock $alt